Corpay price target lowered at Raymond James, says buy shares on weakness

Raymond James lowered the firm’s price target on Corpay (CPAY) to $417 from $434 and keeps an Outperform rating on the shares. Corpay reported mixed Q4 results, and the 2025 outlook was mixed as revenue is largely in line with the Street, but EPS is 4% below given macro-related headwinds, the analyst tells investors in a research note. The firm would take advantage of any weakness in the stock to buy shares, as it sees a compelling risk/reward.